• IBDV VP3 Targets IRF7 for Proteasome-Mediated Degradation

  2026-07-27

  This study uncovers a novel immune evasion mechanism by which infectious bursal disease virus (IBDV) exploits its VP3 protein to target and degrade host IRF7 via the proteasome pathway, undermining antiviral interferon responses in chicken cells. These findings reveal a specific virus-host interaction central to IBDV pathogenesis and highlight the ubiquitin-proteasome system as a key intervention point.

• L-NAME Hydrochloride: Applied NOS Inhibition for Vascular Re

  2026-07-27

  L-NAME Hydrochloride (NG-nitro-L-arginine methyl ester) stands as the gold-standard NOS inhibitor for precise dissection of nitric oxide signaling in cardiovascular, renal, and inflammation models. This article bridges bench workflows with translational insights, highlighting robust protocol parameters, troubleshooting strategies, and the latest reference study breakthroughs that reframe apoptosis and inflammation signaling modulation.

• PD98059 as a MEK Inhibitor: Experimental Workflows & Insight

  2026-07-26

  PD98059, a selective MEK inhibitor, is transforming research into cell signaling, apoptosis, and neuroprotection. This article demystifies applied protocols and troubleshooting, drawing on recent breakthroughs to maximize assay reliability and translational impact.

• Epoxomicin: Precision Proteasome Inhibition in Translational

  2026-07-25

  This article synthesizes mechanistic insights and strategic guidance for translational researchers exploring the ubiquitin-proteasome system. It examines Epoxomicin's mechanism, application in ER stress modeling, protein degradation assays, and anti-inflammatory research, while offering protocol parameters and a differentiated perspective grounded in recent literature.

• O6-Benzylguanine: Potent MGMT Inhibitor for Cancer Research

  2026-07-24

  O6-Benzylguanine is a validated MGMT inhibitor that irreversibly inactivates the DNA repair enzyme MGMT, sensitizing tumor cells to alkylating chemotherapies. This compound enables robust DNA repair inhibition and has demonstrated efficacy in vitro and in vivo, offering a powerful tool for cancer chemotherapy research.

• MG-132 (Z-LLL-al): Optimizing Proteasome Inhibition Workflow

  2026-07-24

  MG-132 (Z-LLL-al) empowers researchers to dissect proteasome function in apoptosis, cell cycle, and cancer research with unmatched precision. This article translates the latest mechanistic insights and protocol enhancements into actionable workflows, ensuring robust results and troubleshooting strategies for advanced experimental designs.

• Meropenem Trihydrate: Carbapenem Antibiotic in Resistance St

  2026-07-23

  Meropenem trihydrate empowers high-fidelity resistance profiling and mechanistic microbiology research. This article details advanced protocols, troubleshooting, and the metabolomics-driven innovations transforming how scientists investigate carbapenem-resistant pathogens.

• nor-Binaltorphimine dihydrochloride in Opioid Receptor Resea

  2026-07-23

  nor-Binaltorphimine dihydrochloride empowers precision dissection of κ-opioid receptor pathways, offering researchers a robust tool for pain modulation and neural circuit analysis. Recent breakthroughs leverage its selectivity to unravel complex brain-to-spinal pain mechanisms with reproducible, quantitative insights.

• TCAIM-Mediated OGDH Regulation: A New Layer in Mitochondrial

  2026-07-22

  Wang et al. (2025) reveal that the mitochondrial DNAJC co-chaperone TCAIM specifically binds and reduces the protein levels of the α-ketoglutarate dehydrogenase (OGDH) complex, thereby suppressing its activity and modulating cellular metabolism. This work identifies a novel post-translational regulatory mechanism with implications for mitochondrial proteostasis and metabolic control.

• DT-TRAP: Precision Target Recognition via Dose and Temperatu

  2026-07-22

  DT-TRAP introduces an optimized chemoproteomic workflow that combines rational dose selection with low-temperature incubation to enhance specificity in protein target identification. This innovation addresses longstanding challenges in chemoproteomics by minimizing nonspecific binding and reducing resource consumption, with significant implications for drug discovery and phosphoprotein analysis.

• Dihydroartemisinin: Advanced Protocols for mTOR & Malaria Re

  2026-07-21

  Dihydroartemisinin, a potent Artemisia plant extract, redefines cell signaling and antimalarial research through robust mTOR pathway inhibition and superior assay reliability. This guide delivers actionable workflows, troubleshooting strategies, and practical insights to maximize reproducibility when using APExBIO’s ultra-pure Dihydroartemisinin in advanced biomedical applications.

• Topotecan (SKF104864): Expanding Antitumor Frontiers in Canc

  2026-07-21

  Explore the molecular intricacies and translational potential of Topotecan (SKF104864) as a topoisomerase I inhibitor. This article delivers advanced insight into its mechanism, pediatric and glioma model utility, and unique assay optimization for modern cancer research.

• TiO2-Nanoparticle Sonodynamic Therapy Induces Ferroptosis to

  2026-07-20

  This study demonstrates that TiO2-nanoparticle–enhanced sonodynamic therapy (SDT) can effectively prevent posterior capsular opacification (PCO) through the induction of ferroptosis in human lens epithelial cells. By establishing precise ultrasound parameters and elucidating redox-driven mechanisms, the research provides a promising, biosafe strategy for addressing a major complication following cataract surgery.

• ARCA EGFP mRNA (5-moUTP): Maximizing Polyadenylated mRNA Per

  2026-07-20

  Explore how ARCA EGFP mRNA (5-moUTP) sets a new benchmark for polyadenylated mRNA in mammalian cell transfection. This article uniquely examines the interplay between mRNA structure, immunogenicity, and storage dynamics, offering advanced assay guidance for fluorescence-based experimentation.

• Comparative Antioxidant and α-Glucosidase Profiles in Taihan

  2026-07-19

  This study systematically compares wild and cultivated Taihangia rupestris leaves, revealing that foothill-cultivated plants possess enhanced flavonoid and phenolic content as well as superior antioxidant and α-glucosidase inhibitory activities. The findings support sustainable cultivation strategies for producing bioactive compounds relevant to antidiabetic research.

16350 records 1/1090 page Next 12345 下5页 Last page